ScoutQuest9 Oct 2026
Solara Active Pharma Sciences541540Earnings release date

Board meeting on October 16, 2026 to consider and approve September quarter results

Board meeting scheduled for Friday, October 16, 2026.

Board Meeting Date
Friday, October 16, 2026
Results Period
quarter and half year ended September 30, 2026
Trading Window Closure
closed for designated persons from October 01, 2026 till 48 hours after the financial results are announced

What was intimated

The company has informed the exchanges that a meeting of its board of directors is scheduled to be held on Friday, October 16, 2026.

At that meeting, the board will consider and approve the unaudited financial results, on both a standalone and a consolidated basis, for the quarter and half year ended September 30, 2026, amongst other matters.

Why the date matters

Trading window

The update also states that, under the company's Code of Conduct for Prohibition of Insider Trading, the trading window for dealing in the securities of the company is closed for designated persons from October 01, 2026, till 48 hours after the announcement of the financial results.

What to take away

The key point for a retail investor is the date: October 16, 2026, when the board is scheduled to consider and approve the unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Alongside it, the trading window for designated persons is closed from October 01, 2026 until 48 hours after the results are announced.

More numbers
  • Trading window reopens 48 hours after results are announced48 hours
Source: BSE · 9 Oct 2026

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.